Home/Filings/4/0000899243-23-001039
4//SEC Filing

Parkinson David Ross 4

Accession 0000899243-23-001039

CIK 0001633932other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 6:18 PM ET

Size

6.3 KB

Accession

0000899243-23-001039

Insider Transaction Report

Form 4
Period: 2022-12-22
Parkinson David Ross
DirectorPresident and CEO
Transactions
  • Purchase

    Common Shares

    2022-12-30$2.60/sh+3,067$7,97456,542 total
  • Purchase

    Common Shares

    2022-12-22$2.39/sh+21,367$51,06753,475 total
Footnotes (1)
  • [F1]The amount reflects the acquisition of shares pursuant to the ESSA Pharma Inc. Employee Stock Purchase Plan.

Issuer

ESSA Pharma Inc.

CIK 0001633932

Entity typeother

Related Parties

1
  • filerCIK 0001451935

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:18 PM ET
Size
6.3 KB